RanChip Insight 360

A 250-plus biomarker comprehensive health assessment using proprietary Biochip Array Technology, covering autoimmune markers, tumour markers, digestive health, genetic risk assessment, and a stool sample analysis in addition to the full range of blood-based organ and hormonal screens. Includes a free retest at six months.

The RanChip Insight 360 represents a step change from the Everyman and Everywoman panels, adding approximately 100 additional biomarkers that extend into clinical territories rarely covered in standard health checks. The distinguishing feature is the use of Randox's proprietary Biochip Array Technology — a multiplexed immunoassay platform that analyses dozens of markers simultaneously from a single sample, enabling the breadth of coverage without requiring multiple vials or extended appointment times. Beyond the standard blood-based categories, this panel introduces autoimmune markers, Epstein-Barr virus screening, pituitary and adrenal function, stress hormones, and an initial tier of genetic risk assessment. Tumour-associated markers are included as standard rather than as an add-on. The digestive and bowel health component requires a stool sample collected at home after the clinic appointment, screening for gut inflammation and function markers that blood tests alone cannot capture. The 10-working-day turnaround reflects the additional analytical complexity compared to the express-capable Everyman and Everywoman panels. At 495 pounds, the RanChip Insight 360 fills the gap between the core health checks and the premium Signature series, offering substantially more depth — particularly around autoimmune, digestive, and early genetic risk screening — without the multi-thousand-pound commitment of the top-tier packages.